Log In
Print
BCIQ
Print
Print this Print this
 

mocetinostat (MGCD0103)

Also known as: formerly MG-0103

  Manage Alerts
Collapse Summary General Information
Company Mirati Therapeutics Inc.
DescriptionIsoform-selective small molecule histone deacetylase (HDAC) inhibitor
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today